Literature DB >> 7733451

Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite.

C P Verdon1, B A Burton, R L Prior.   

Abstract

An assay for the simultaneous measurement of nitrite and nitrate, products of nitric oxide metabolism, is described. Others have reported pretreating sample by using nitrate reductase (NR) and NADPH to reduce endogenous NO3- before assaying the resultant NO2- using the Griess reaction. However, we found that the NADP+ formed during pretreatment interfered with the Griess reaction when NADPH was used at concentrations necessary to drive the NR reaction. For instance, 500 microM NADP+ in 100 microM NaNO3- (without NR) causes a 90% interference with the formation of Griess reaction product. To limit interference, we modified the method by decreasing the NADPH concentration to 1 microM. NADPH was regenerated by coupling the NR reaction with that catalyzed by glucose-6-phosphate dehydrogenase (GD). Using this method, NaNO3- standard curves were linear up to 100 microM and coincided with control curves obtained using NaNO2- incubated in parallel. Addition of urine up to a strength of 20% did not interfere with the assay. Comparison with an alternative assay based on cadmium reduction resulted in the following linear regression: [Cd method] = 0.915*[NR-GD method] + 0.37, r2 = 0.997. Coupling GD to NR to recycle NADPH allows this cofactor to be used at a low concentration so that interference with the Griess reaction is negligible.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733451     DOI: 10.1006/abio.1995.1079

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  53 in total

1.  21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties.

Authors:  M Paul-Clark; P Del Soldato; S Fiorucci; R J Flower; M Perretti
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  Analytical chemistry of nitric oxide.

Authors:  Evan M Hetrick; Mark H Schoenfisch
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2009       Impact factor: 10.745

3.  Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients.

Authors:  Nuntiya Somparn; Upa Kukongviriyapan; Wichittra Tassaneeyakul; Arunee Jetsrisuparb; Veerapol Kukongviriyapan
Journal:  Eur J Clin Pharmacol       Date:  2006-11-21       Impact factor: 2.953

4.  An improved method to measure nitrate/nitrite with an NO-selective electrochemical sensor.

Authors:  Yong Chool Boo; Sarah L Tressel; Hanjoong Jo
Journal:  Nitric Oxide       Date:  2006-09-15       Impact factor: 4.427

5.  Assessing the physiological concentration and targets of nitric oxide in brain tissue.

Authors:  Catherine N Hall; David Attwell
Journal:  J Physiol       Date:  2008-06-05       Impact factor: 5.182

6.  Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients.

Authors:  Carmina Montoliu; Blanca Piedrafita; Miguel A Serra; Juan A del Olmo; Antonio Ferrandez; José M Rodrigo; Vicente Felipo
Journal:  J Mol Med (Berl)       Date:  2007-01-10       Impact factor: 4.599

7.  Induced nitric oxide (NO) synthesis in heterologous nephrotoxic nephritis; effects of selective inhibition in neutrophil-dependent glomerulonephritis.

Authors:  S N Waddington; K Mosley; V Cattell
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

8.  Role of nitric oxide (NO) metabolism and inflammatory mediators in childhood obesity.

Authors:  András Hrabák; László Derzbach; Ildikó Csuka; Tamás Bajor; Anna Körner
Journal:  Inflamm Res       Date:  2011-08-27       Impact factor: 4.575

9.  Mechanism of action of 5-nitrothiophenes against Mycobacterium tuberculosis.

Authors:  Ruben C Hartkoorn; Olga B Ryabova; Laurent R Chiarelli; Giovanna Riccardi; Vadim Makarov; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

10.  Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-beta thalassemia.

Authors:  Veerapol Kukongviriyapan; Nuntiya Somparn; Laddawan Senggunprai; Auemduan Prawan; Upa Kukongviriyapan; Arunee Jetsrisuparb
Journal:  Pediatr Cardiol       Date:  2007-09-22       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.